Similar articles

• Problems and solutions in the evaluation of hormone receptors in breast cancer.

  Allred DC. Allred DC. J Clin Oncol. 2008 May 20;26(15):2433-5. doi: 10.1200/JCO.2007.15.7800. J Clin Oncol. 2008. PMID: 18487563 No abstract available.
• p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

  Liang Y, Wu J, Stancel GM, Hyder SM. Liang Y, et al. J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):173-82. doi: 10.1016/j.jsbmb.2004.12.011. Epub 2005 Jan 28. J Steroid Biochem Mol Biol. 2005. PMID: 15860260
• [Hormonal and genotoxic aspects of BRCA1-associated carcinogenesis].

  Bershteĭn LM. Bershteĭn LM. Vopr Onkol. 2007;53(6):642-53. Vopr Onkol. 2007. PMID: 18416131 Review. Russian. No abstract available.
• The importance of normal and abnormal oestrogen receptor in breast cancer.

  McGuire WL, Chamness GC, Fuqua SA. McGuire WL, et al. Cancer Surv. 1992;14:31-40. Cancer Surv. 1992. PMID: 1423328 Review.
• [Experimental and clinical experiences with steroid hormone receptors in breast cancer].

  Jonat W. Jonat W. Wien Klin Wochenschr. 1984 Jun 22;96(13):499-508. Wien Klin Wochenschr. 1984. PMID: 6089443 German.